CELISA PAINE: Open Payments
NPI 1629644190 · ROME, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 16 payments from 12 companies in 2025. Trend: 2023 $77 · 2024 $533 · 2025 $289
Food & beverage: $289
| Company | Payments | Amount |
|---|---|---|
| SHIELD THERAPEUTICS INC | 2 | $45 |
| Novo Nordisk Inc | 2 | $33 |
| Sumitomo Pharma America, Inc. | 2 | $31 |
| Lilly USA, LLC | 2 | $31 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| PFIZER INC. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $18 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $17 |
| ABBVIE INC. | 1 | $17 |
Products named: ACCRUFER, Wegovy, GEMTESA, TZIELD, PREVNAR 20, CAPLYTA, NEXLETOL, Kerendia.
Industry payments across GA — which companies pay providers there.
